Provention Bio, Inc. Quarterly Marketable Securities, Current in USD from Q4 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Provention Bio, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2019 to Q4 2022.
  • Provention Bio, Inc. Marketable Securities, Current for the quarter ending December 31, 2022 was $121M, a 615% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $121M +$104M +615% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $83.1M +$71.7M +627% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $26.6M +$2.04M +8.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $10.1M -$16.7M -62.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $16.9M -$2.61M -13.4% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $11.4M -$17.3M -60.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $24.6M -$1.67M -6.36% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $26.8M -$12.6M -32% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $19.5M -$26.7M -57.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $28.7M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $26.3M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $39.5M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $46.2M Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.